How does the DCISionRT test benefit me?
The DCISionRT® test indicates your individual risk of recurrence and expected benefit from radiation therapy. This allows you and your physician to formulate a personalized treatment plan using your underlying DCIS biology.
The information provided by DCISionRT can help your physician to better balance the benefit of a treatment with the risk of side-effects.
DCISionRT empowers women with information about their biological risk profile. Before you make a decision, Know Your Risk™
The Most Accurate Test for DCIS
The DCISionRT test quantifies the risk of your DCIS coming back (recurring) as well as predicting whether radiation therapy will benefit you.
Your Biology
DCISionRT looks at the biology of your DCIS using a comprehensive assessment of the key pathways implicated in progression of breast cancer.
Your DCISionScore™
Intelligent risk algorithms built with AI trained with thousands of patients calculate your individualized DCISionScore. Your DCISionScore gives your personal prognosis after treatment with surgery alone or surgery and RT.
Your Decision
DCISionRT helps you and your doctor formulate a more precise treatment plan to balance treatment benefit with the risk of side effects by assessing your underlying DCIS biology.
FAQs
Case Studies
The DCISionRT® test indicates your individual risk of recurrence and expected benefit from radiation therapy.
Example 1
Age: 54 years | DCIS Grade: High (Grade 3) | DCIS size: 12mm
Before DCISionRT
Risk Assessment
Traditional Clinpath Features
TREATMENT PLAN:
Surgery with radiation therapy
TREATMENT RATIONALE:
Radiation therapy after breast conserving surgery is recommended based on presence of high grade (grade 3) DCIS.
After DCISionRT
Risk Assessment
TREATMENT PLAN:
Breast conserving surgery
TREATMENT RATIONALE:
Because the patient has a Low DCISionRT score, the Physician and patient decide to defer radiation therapy and elect breast conserving surgery in order to preserve the option for radiation therapy should the patient have a recurrence in the future.
Example 2
Age: 65 years | DCIS Grade: Low (Grade 1) | DCIS size: 6mm
Before DCISionRT
Risk Assessment
Traditional Clinpath Features
TREATMENT PLAN:
Breast conserving surgery
TREATMENT RATIONALE:
Traditional risk assessment using clinicopathologic features indicates patient could be considered “low risk” and therefore, the patient and physician elect to forego radiation therapy.
After DCISionRT
Risk Assessment
TREATMENT PLAN:
Surgery with radiation therapy
TREATMENT RATIONALE:
New information from DCISionRT indicates the patient is at Elevated Risk if treated with surgery alone. The patient and physician decide to use radiation therapy-–despite traditionally low risk clinicopathalogic features—due to the large risk reduction from radiation therapy.
Insurance
- PreludeDx accepts all insurance plans
- Financial assistance may be available for patients meeting certain requirements (contact Customer Care for details)